Harmony Biosciences Holdings, Inc. (HRMY) insider trading.
In Q3 2026, insiders at Harmony Biosciences Holdings, Inc. reported 15 non-derivative transactions on 3 Forms 3, 4 and 5: 0 open-market purchases and 7 sales worth $3.1M.
- Transactions
- 15
- Purchases (P)
- 0
- Sales (S)
- 7
- Net shares, P minus S
- -72,406
- Insiders
- 1
- Last filed
- 2026-09-18
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Budur Kumar | Officer · CHIEF MEDICAL OFFICER | 15 | 0 | 7 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-18 | Budur Kumar | M (A) | 10,406 | $30.69 | 23,521 | Form 4 |
| 2026-09-18 | Budur Kumar | S (D) | 35,852 | $43.05 | 13,115 | Form 4 |
| 2026-09-18 | Budur Kumar | M (A) | 25,446 | $30.27 | 48,967 | Form 4 |
| 2026-09-17 | Budur Kumar | M (A) | 400 | $30.69 | 13,515 | Form 4 |
| 2026-09-17 | Budur Kumar | M (A) | 400 | $30.27 | 13,915 | Form 4 |
| 2026-09-17 | Budur Kumar | S (D) | 800 | $43 | 13,115 | Form 4 |
| 2026-09-16 | Budur Kumar | S (D) | 1,800 | $43.01 | 13,115 | Form 4 |
| 2026-09-16 | Budur Kumar | M (A) | 900 | $30.27 | 14,915 | Form 4 |
| 2026-09-16 | Budur Kumar | M (A) | 900 | $30.69 | 14,015 | Form 4 |
| 2026-09-08 | Budur Kumar | M (A) | 10,754 | $30.27 | 36,069 | Form 4 |
| 2026-09-08 | Budur Kumar | S (D) | 22,954 | $43.1 | 13,115 | Form 4 |
| 2026-09-08 | Budur Kumar | M (A) | 12,200 | $30.69 | 25,315 | Form 4 |
| 2026-09-08 | Budur Kumar | S (D) | 1,000 | $42.79 | 13,115 | Form 4 |
| 2026-09-08 | Budur Kumar | S (D) | 4,500 | $42.25 | 14,115 | Form 4 |
| 2026-09-04 | Budur Kumar | S (D) | 5,500 | $41.98 | 18,615 | Form 4 |
Transaction codes in this quarter
Get HRMY insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1802665&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · HRMY company page · Harmony Biosciences Holdings, Inc. on SEC.gov
Questions
Are insiders buying or selling Harmony Biosciences Holdings, Inc. (HRMY)?
In Q3 2026, insiders at Harmony Biosciences Holdings, Inc. reported 15 non-derivative transactions on 3 Forms 3, 4 and 5: 0 open-market purchases and 7 sales worth $3.1M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Harmony Biosciences Holdings, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/hrmy.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.